Oldenburg J, Goldmann G, Marquardt N, Horneff S, Klein C, Albert T, Perera R. Real-world clinical experience of extended half-life recombinant factor VIII Fc fusion protein (rFVIIIFc) in comparison to conventional factor products in patients with severe hemophilia A . J Current Med Res Opinion [Internet]. 2021 May 21 [cited 2024 May 20];4(05):950-6. Available from: http://cmro.in/index.php/jcmro/article/view/422